BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Autoimmunity
,
Doxorubicin
,
rs3825942
,
SNCA
,
Angiogenesis
,
Diabetes mellitus
,
Breast
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
long-acting insulin
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
KLHL24
STON1
CREBRF
EGR3
EGR1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
LEE_BMP2_TARGETS_DN
WEI_MYCN_TARGETS_WITH_E_BOX
KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Breast cancer MCF7 cells expressing IGF1R of INSR isoforms IRA or IRB treated with insulin analogues
Explore Curated Studies Results
Literature
Most Relevant Literature
Management of diabetic cats with long-acting insulin.
The effects of increasing doses of 2 preparations of long-acting insulin on short-term plasma profil…
Glycaemic control in patients with type 2 diabetes switching from premixed insulin to long-acting ba…
Insulin degludec: a long-acting modern insulin analogue with a predictable pharmacokinetic/pharmacod…
Revisiting the efficacy of long-acting insulin analogues on adults with type 1 diabetes using mixed-…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus
Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics
The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients …
Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days
Treatment Trial Evaluating Long Acting Insulin in Type 1 Diabetes
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ